WPI 2227 Pill - brown & white capsule/oblong
Pill with imprint WPI 2227 is Brown & White, Capsule/Oblong and has been identified as Flutamide 125 mg. It is supplied by Watson Pharmaceuticals, Inc.
Flutamide is used in the treatment of Prostate Cancer; Hirsutism and belongs to the drug classes antiandrogens, hormones/antineoplastics. There is positive evidence of human fetal risk during pregnancy. Flutamide 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WPI 2227
Flutamide
- Imprint
- WPI 2227
- Strength
- 125 mg
- Color
- Brown & White
- Shape
- Capsule/Oblong
- Availability
- Prescription only
- Drug Class
- Antiandrogens, Hormones/antineoplastics
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Watson Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 00591-2466 (Discontinued)
- Inactive Ingredients
-
lactose monohydrate,
magnesium stearate,
povidone,
corn starch,
sodium lauryl sulfate,
ferrosoferric oxide,
gelatin,
ferric oxide red,
ferric oxide yellow,
titanium dioxide,
D&C Yellow No. 10,
FD&C Blue No. 1,
FD&C Blue No. 2,
FD&C Red No. 40,
butyl alcohol,
propylene glycol
Note: Inactive ingredients may vary.
More about flutamide
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- Drug class: antiandrogens
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
